Literature DB >> 17850893

A quantitative assay for measuring clearance of adenovirus vectors by Kupffer cells.

Jeffrey S Smith1, Zhili Xu, Andrew P Byrnes.   

Abstract

Kupffer cells are a major barrier to systemic adenovirus (Ad) gene therapy because they rapidly and efficiently clear virions from the circulation. The lack of a straightforward quantitative technique for selectively measuring uptake of Ad by Kupffer cells has made it difficult to study the mechanisms by which they recognize Ad. A new method was developed that relies on immunofluorescent detection of Ad within Kupffer cells in mouse liver sections, followed by confocal microscopy and computerized image analysis. The method is sensitive, quantitative and reproducible, with a linear range spanning two orders of magnitude. As an example of the utility of this method, it was found that pre-injecting mice with polyinosinic acid reduces accumulation of Ad in Kupffer cells by approximately 90%.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17850893     DOI: 10.1016/j.jviromet.2007.08.009

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  18 in total

Review 1.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

Review 2.  Innate immunity to adenovirus: lessons from mice.

Authors:  Svetlana Atasheva; Jia Yao; Dmitry M Shayakhmetov
Journal:  FEBS Lett       Date:  2019-12-08       Impact factor: 4.124

3.  Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo.

Authors:  Jie Tian; Zhili Xu; Jeffrey S Smith; Sean E Hofherr; Michael A Barry; Andrew P Byrnes
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

4.  Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Authors:  Zhili Xu; Jie Tian; Jeffrey S Smith; Andrew P Byrnes
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

5.  NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo.

Authors:  Masataka Suzuki; Racel Cela; Terry K Bertin; Gautam Sule; Vincenzo Cerullo; John R Rodgers; Brendan Lee
Journal:  Hum Gene Ther       Date:  2011-07-08       Impact factor: 5.695

6.  Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery.

Authors:  Bin Shi; Ed Keough; Andrea Matter; Karen Leander; Stephanie Young; Ed Carlini; Alan B Sachs; Weikang Tao; Marc Abrams; Bonnie Howell; Laura Sepp-Lorenzino
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

7.  Glycyrrhetinic Acid-Mediated Polymeric Drug Delivery Targeting the Acidic Microenvironment of Hepatocellular Carcinoma.

Authors:  Jinming Zhang; Min Zhang; Juan Ji; Xiefan Fang; Xin Pan; Yitao Wang; Chuanbin Wu; Meiwan Chen
Journal:  Pharm Res       Date:  2015-07-07       Impact factor: 4.200

8.  Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor.

Authors:  Zhili Xu; Jeffrey S Smith; Jie Tian; Andrew P Byrnes
Journal:  Mol Ther       Date:  2009-12-01       Impact factor: 11.454

9.  Differential type I interferon-dependent transgene silencing of helper-dependent adenoviral vs. adeno-associated viral vectors in vivo.

Authors:  Masataka Suzuki; Terry K Bertin; Geoffrey L Rogers; Racel G Cela; Irene Zolotukhin; Donna J Palmer; Philip Ng; Roland W Herzog; Brendan Lee
Journal:  Mol Ther       Date:  2013-01-15       Impact factor: 11.454

10.  Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver.

Authors:  Nelson C Di Paolo; Nico van Rooijen; Dmitry M Shayakhmetov
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.